DOI: http://dx.doi.org/10.18203/2349-3933.ijam20204022

A cross-sectional study for determining the perception and preferences of immunity boosters for protection against COVID-19

Dhairya P. Nanavaty, Ankushi A. Sanghvi, Manav S. Mehta, Sarbari Gupta, Gurusharan Dumra

Abstract


Background: The World Health Organisation declared the novel coronavirus (COVID-19) outbreak as a global pandemic on March 11, 2020.  The consumption of vitamins, especially C, D, and zinc, hydroxychloroquine, and Arsenicum album 30 (homeopathy), has increased tremendously. However, the clinical trial showing the benefits of these agents is still underway though there have been a lot of discussion about these in print, electronic, and social media.

Method: A questionnaire-based observational study was conducted. The participants were inquired about the use of any type of immunity booster by them and the source of information regarding the same. The data was analysed using Excel and Python.

Results: Our study included 1147 participants. A dramatic increase of 21.97% in the consumption of immunity-boosting agents after the COVID-19 outbreak was observed, maximally in Ayurveda. The major source of information for immunity-boosters was provided by friends/family/relatives (50.4%). 52.7% of the respondents selected Ayurveda as their preferred choice of immunity booster (prophylaxis). If the respondents were to develop any of the COVID-19 symptoms, the majority (45.1%) decided to contact their family doctor, and 53.7% chose Allopathy as their preferred system for treatment. 91.5% of the respondents agreed to take a vaccine if it develops.

Conclusion: There has been a boom in the immunity booster drug market because people are selecting immunity boosters despite no scientific background. It is imperative to educate people regarding the same and also conduct research studies to find benefits, if any.


Keywords


Immunity, Boosters, Ayurvedic medicine, Homeopathy, COVID-19 vaccine

Full Text:

PDF

References


World Health Organization -Director-General's opening remarks at the media briefing on COVID-19 -March 11, 2020. Available at https://www.who.int/ dg/speeches/detail/who-irector-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed on 25 August 2020.

Worldometer. Available at: https://www.worldo meters.info/coronavirus/country/india/. Accessed on 25 August 2020.

Ministry of AYUSH-Ayurveda's immunity boosting measures for self-care during COVID 19 crisis- Available at https://www.mohfw.gov.in/pdf/ ImmunityBoostingAYUSHAdvisory.pdf. Accessed on 25 August 2020.

Ministry of health and family welfare-advisory on the use of hydroxychloroquine. Available at https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophylaxisforSARSCoV2infection.pdf. Accessed on 25 August 2020.

National Institute of Health-clinical trials.gov Available at: https://clinicaltrials.gov/ct2/ show/NCT04334928. Accessed on August 25, 2020.

Overbeck S, Rink L, Haase H. Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Archivumimmunologiae et Therapiaeexperimentalis. 2008;56(1):15-30.

Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211.

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.

Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chinese J Integrative Med. 2020;17:1-8.

National Institue of Health- COVID treatment guidelines. Available at: https://www.COVID-19treatmentguidelines.nih.gov/overview/prevention-of-sars-cov-2/. Accessed on 25 August 2020.

Wang PW, Lu WH, Ko NY, Chen YL, Li DJ, Chang YP, et al. COVID-19-Related Information Sources and the Relationship with Confidence in People Coping with COVID-19: Facebook Survey Study in Taiwan. J Med Int Res. 2020;22(6):200-21.

Jawla S, Gupta AK, Singla R, Gupta V. General awareness and relative popularity of allopathic, ayurvedic and homeopathic systems. J Chem Pharm Res. 2009;1(1):105-12.

Centers for Disease Control and Prevention. Information for clinicians on investigational therapeutics for patients with COVID-19. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html. Accessed on 25 August 2020.

Ministry of health and family welfare- Awareness Available at https://www.mohfw.gov.in/pdf/ socialdistancingEnglish.pdf. Accessed on 25 August 2020.

Kafle G, Bhattarai I, Shrestha AK, Siwakoti M. Why do patients choose to consume Ayurvedic Medicines in Nepal? An exploratory study. Int J Ayurvedic Med. 2018;9(4):250-7.

Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: A cross-sectional study in Indonesia. Frontiers in Public Health. 2020;8.

Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;12:1-5.